What are the key competitors & why?
-
What are the main competitors from a mechanistic and/or disease segment perspective?
-
What is known about their profiles and development plan?
-
What is the level of threat from each competitor?
-
How are the competitors differentiated?
-
What impact will the competition have on the future treatment landscape?
Posted in: PHASE II & III PREPARATION